Bioadditive manufacturing of hybrid tissue scaffolds for controlled release kinetics by Özbolat, İbrahim T. et al.
 1 Copyright © 2012 by ASME 
 
BIOADDITIVE MANUFACTURING OF HYBRID TISSUE SCAFFOLDS FOR 
CONTROLLED RELEASE KINETICS 
 
 
Ibrahim T. Ozbolat 
Mechanical and Industrial Engineering 
Department, The University of Iowa 
Iowa City, IA, USA 
AKMB Khoda 
Industrial and Systems Engineering  
Department, University at Buffalo 
Buffalo, NY, USA 
 
Bahattin Koc 
Faculty of Engineering and Natural Sciences, Sabanci University 
Tuzla, Istanbul, TURKEY 
 
 
Abstract 
Development of engineered tissue scaffolds with superior 
control over cell-protein interactions is still very much infancy. 
Advancing through heterogeneous multifold scaffolds with 
controlled release fashion enables synchronization of 
regenerating tissue with the release kinetics of loaded 
biomolecules. This might be an engineering challenge and 
promising approach for improved and efficient tissue 
regeneration. The most critical limitations: the selection of 
proper protein(s) incorporation, and precise control over 
concentration gradient and timing should be overcome. Hence, 
tissue scaffolds need to be fabricated in a way that proteins or 
growth factors should be incorporated and released in a specific 
spatial and temporal orientation to mimic the natural tissue 
regeneration process. Spatial and temporal control over 
heterogeneous porous tissue scaffolds can be achieved by 
controlling two important parameters: (i) internal architecture 
with enhanced fluid transport, and (ii) distribution of scaffold 
base material and loaded modifiers.  
In this research, heterogeneous tissue scaffolds are designed 
considering both the parameters. Firstly, the three-dimensional 
porous structures of the scaffold are geometrically partition into 
functionally uniform porosity regions and controlled spatial 
micro-architecture has been achieved using a functionally 
gradient porosity function. The bio-fabrication of the designed 
internal porous architecture has been performed using a single 
nozzle bioadditive manufacturing system. The internal 
architecture scheme is developed to enhance fluid transport 
with continuous base material deposition 
Next, the hybrid tissue scaffolds are modeled with varying 
material characteristics to mediate the release of base material 
and enclosed biological modifiers are proposed based on tissue 
engineering requirements. The hybrid scaffolds are fabricated 
for spatial control of biomolecules and base material to 
synchronize the release kinetics with tissue regeneration. A 
pressure-assisted multi-chamber single nozzle bioadditive 
manufacturing system is used to fabricate hybrid scaffolds. 
1. Introduction 
Current medical procedures aim to restore tissue function to 
patients with diseased or damaged tissues through tissue 
transplantation and implants. Tissue Engineering, an 
interdisciplinary field of biology, biomaterials and engineering, 
is seeking to restore tissue functions by developing engineered 
scaffolds providing optimum environment for cell attachment 
and growth, tissue regeneration, fluid movement and structural 
integrity [1]. Engineered scaffold attempts to mimic the 
complexity of both external and internal architecture of 
replaced tissue in a way that optimal microenvironment is 
designed for the cells to culture and develop into tissues. 
Optimal microenvironment can be achieved by signaling 
cellular activity through delivering vital biological modifiers 
such as proteins, growth factors and drugs. Release of these 
modifiers with spatial and temporal gradient concentration 
mediates tissue regeneration process. It develops a mental 
biology, in which cells are guided by a mechanism with respect 
to obtained spatial and directional cues [2]. Moreover, 
mediating the degradation by controlling the scaffold geometry 
in micro-scale could have a big impact on cell growth and 
proliferation. MacKay and Miller [3] studied effects of 
nutritional and botanical support on wound healing process and 
concluded that adequate protein intake is necessary for proper 
wound healing. 
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Therefore, it is essential to release encapsulated biological 
modifier in a controlled fashion since the incorporated 
modifiers need to maintain their integrity to stimulate desirable 
cells to achieve biological response and thereafter the 
degradation of the release system [4]. As a result, scaffolds in 
tissue engineering should be fabricated in way that they enable 
controlled release scheme of biological modifiers with distinct 
spatial gradient to guide specific cues to the cellular 
microenvironment. Weiss et al [5] have presented a Bayesian 
methodology for computer-aided experimental design of 
heterogeneous fibrin-based scaffolds having spatial distribution 
of growth factors designed to induce and direct the growth of 
new tissue as the scaffold degrades, however bioactive 
molecules are discrete entities and need to be spatially 
distributed in a controlled fashion within the porous structure. 
 
In this paper, proteins, growth factors and cells etc. are named 
with a general term “biological modifiers”. Development of 
engineered tissue scaffolds with superior control over cell-
biological modifier interactions is still very much infancy. 
Advancing through heterogeneous multifold scaffolds with 
controlled release fashion enables synchronization of 
regenerating tissue with the release kinetics of loaded 
biological modifiers. This might be an engineering challenge 
and promising approach for improved and efficient tissue 
regeneration. The most critical limitations: the selection of 
proper biological modifier(s) incorporation, precise control 
over concentration gradient and timing should be overcome. 
Hence, tissue scaffolds need to be fabricated in a way that 
biological modifiers should be incorporated and released in a 
specific spatial and temporal orientation to mimic the natural 
tissue regeneration process. In this paper, spatial and temporal 
control over heterogeneous tissue scaffolds is achieved by 
controlling two important parameters: (i) internal architecture 
with controlled fluid transport, and (ii) distribution of scaffold 
base material and loaded modifiers. 
2. Materials and Methods 
2.1 Materials 
Sodium alginate (SA) from brown algae and calcium chloride 
were purchased from Sigma-Aldrich, USA. Nozzle tips for 
dispensing systems were purchased from Nordson EFD, USA. 
3-5% (w/v) alginate solutions were prepared by suspending 
alginate into deionized (DI) water and stirred at room 
temperature for a day. Calcium chloride was suspended in DI 
water to obtain 0.6% (w/v) calcium chloride solution for 
crosslinking purposes. Micro-glass beads in powder form were 
purchased from Corpuscular Inc. to represent biomolecules.   
2.2 Experimental Setup 
2.2.1 Single Nozzle Bioadditive Manufacturing Platform 
Biofabrication of the porous hybrid scaffolds with controlled 
internal architecture is performed using a 3D micro-nozzle 
bioadditive manufacturing system (see Fig.1). The fabrication 
process is biologically compatible. Sodium alginate, a type of 
hydrogel widely used in cell immobilization, cell 
transplantation, and tissue engineering, is preferred as 
biomaterial due to its biocompatibility and formability. Sodium 
alginate solution is filled in a reservoir and a pneumatic system 
is deployed to flow the solution via the micro-nozzles (150 
μm). The system runs at room temperature under low pressure 
(0–8 psi). The reservoir is mounted on the dispensing system 
that is driven by a 3D motion control. The system is driven by a 
FlashCut CNC 3D motion controller. A PC is connected to the 
system to control the motion in 3D. Toolpath for the motion is 
realized through importing CAD models in stereolithography 
(STL) format followed by G-code generation using visual 
basic-based in-house developed script. The calcium chloride 
solution is then dispensed onto the printed alginate structure 
through another nozzle to provide crosslinking between 
alginate anions and the calcium cations to form the hydrogel. A 
pink color pigment is used only for proper visualization 
purposes. 
Figure 1: Single Nozzle Bioadditive Manufacturing Platform 
2.2.2 Multi-Chamber Single Nozzle Bioadditive Manufacturing 
Platform 
Biofabrication of multi-material hybrid tissue scaffolds is 
performed by using a multi-chamber single nozzle bioadditive 
manufacturing system. Similar to single nozzle bioadditive 
manufacturing platform, fabrication process is biologically 
compatible and the system runs in room temperature under low 
pressure (0-8 psi) to reduce fluidic shear forces that can damage 
incorporated modifiers or diminish their active properties. The 
multi-chamber single nozzle assembly is mounted on the 3D 
motion control unit. The multi-chamber single nozzle assembly 
(see Fig. 2) consists of multiple biomaterial chambers and a 
single converging nozzle unit, where two different biomaterials 
can be mixed statically and extruded with unique properties. 
The volume of the static mixture nozzle is optimized while 
nozzle volume determines the quality and the evenness of 
physical properties of the dispensed biomaterial. Biomaterial 
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chambers are connected to a pressure control unit, where the air 
pressure assists in extruding the biomaterial through the 
dispensing unit. Material flow and concentration through the 
nozzle is controlled by regulating positive chamber pressures 
connected to the air pressure control unit. Mixing two different 
concentrations from each chamber enables dispensing varying 
concentration of alginate and loaded microspheres by time. 
Final solutions were deposited through 250 µm nozzle tip. The 
system allows extrusion of continuous customized filaments 
with variational biomaterial and biological modifier properties 
enabling controlled release kinetics. A similar method is used to 
crosslink alginate solution with calcium chloride solution as 
described in section 2.2.1. Dark field images of fabricated 
samples are taken by 5.0x1.0x1.0 optic lenses. 
Figure 2: Schematic of the multi-chamber single nozzle 
bioadditive manufacturing platform 
 
2.3 Modeling of Geometric Variation in Tissue Scaffolds  
Natural tissues and organs are not homogenous rather they 
have layers of tissue with one or more specific function that 
generate natural functional gradients over their structure [6]. 
Thus, tissue scaffolds with controlled variation in porosity over 
their architectures could have significant impact on functional, 
mechanical and biological behavior of scaffolds [7]. Thus, 
porosity level in tissue scaffolds should vary spatially to mimic 
the formation of natural tissues based on location dependent 
mechanical, biological and functional requirements over their 
structures. Moreover, permeability needs to be controlled 
spatially to provide enhanced nutrient, water and oxygen 
transport throughout the tissue scaffold. This can be mimicked 
by partitioning the entire scaffold into different functionally 
uniform regions each having different porosity levels. This 
enables improved flow of the media through the internal 
regions and mediates the release of loaded modifier in internal 
regions. To mimic the functional gradient in porosity of the 
replaced tissue, the scaffold area can be discretized into a 
number of uniform regions. To achieve these uniform porosity 
regions, a non-uniform-offsetting operation [8] is used to 
partition the structure. Similar discretization approach is used 
to partition tissue scaffolds with variational biomaterial and 
biomolecule composition to control release kinetics 
spatiotemporally.  
3. RESULTS 
For implementation purpose, a lumbar vertebra solid model is 
obtained by extracting the 3D geometry through reserve 
engineering. Roland Picza LPX-60, USA laser scanner is used 
to generate scan data and converted into CAD model through 
Pixform software. Then, the model is inputted into NURBS 
modeling software Rhinoceros 4.0. The desired number of 
regions is generated and sliced. Next, toolpath optimization 
method presented in our earlier work [9] is used to develop 
toolpath plan for the lumbar vertebrae slices. The generated 
toolpath plan is then verified using Flashcut software and 
exported into solid freeform fabrication system to build the 
designed scaffold. Then, the single nozzle bioadditive 
manufacturing platform is used to fabricate the model with 
nozzle tip diameter of 150 µm with controlled variational 
porosity along the scaffold architecture. Figure 3 illustrates the 
fabricated lumbar vertebrae scaffold. Two consecutive vertebra 
slices are printed with five different porosity regions of 84.6%, 
83.6%, 79.3%, 78.1% and 76.2%, where the prosoity decreases 
through the innnermost region to meet tissue engineering 
requirements (see Fig. 3(a)). A sample scaffold with 18 layers is 
also demonstrated to show the effectivesses of the system in 
3D.   
Figure 3: (a) Two consecutive fabricated vertebra slices with 
five different porosity region of 84.6%, 83.6%, 79.3%, 78.1% 
and 76.2% (b) and 3D fabricated vertebra with 18 slices. 
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Fabricated vertebra sample is analzed through imaging study 
using Image J software. As presented in Table 1, the porosity 
level of fabricated sample is slightly different than that of 
designed scaffold. The permeability of the fabricated scaffold is 
also characterized by the imaging study to understand the 
effectiveness of the proposed optimization model. By appliying 
the toolpath optimization strategy developed in our earlier work 
[9], permeability of the fabricated vertebrae is improved by 
21.1% compare to that without toolpath optimization. 
 
Table 1 Characterization of the fabricated vertebra scaffold with 
variational porosity using imaging. 
 
 
The multi-chamber single nozzle bioadditive manufacturing 
platform is used to manufacture hybrid tissue scaffolds with 
variational biomaterial and biomolecule concentrations. Figure 
4 shows concentration level of sodium alginate and 
biomolecules in different regions on a tissue scaffold illustrated 
in Fig. 5(a). Requirements presented in Fig. 4 are assumed to be 
tissue engineering needs. In general, alginate concentration 
over 5% is not suitable for cell viability and concentration 
under 1% does not provide good mechanical integrity [10]. 
Thus, alginate concentration is preferred to be in the range of 
3% to 5%. Moreover, modifier concentration under 1% is in 
biologically relevant range [11]. Then, the concentration 
information is inputted into the fabrication system. A double 
layer of CAD model is printed through the deposition system 
with blending of two different alginate and modifier 
concentrations. Yellow and red inks in RGB are used for each 
alginate solutions to represent regional differentiation for 
visualization purposes. Only top layer is printed due to 
diffusive characteristics of color inks.  
 
Based on requirements presented in Fig. 4, a sample structure is 
printed in which the alginate concentration increases from the 
outermost region (Region 1) through the innermost region 
(Region 4). Fig. 5(a) shows a sample fabricated wound dressing 
with 4 regions, in which regions are occupied by different 
alginate and modifier concentration based on the profile 
presented in Fig. 4. Fig. 5(b) demonstrates dark field image of 
biomolecules of a randomly picked region on the tissue 
scaffold. As can be seen in Fig. 5(b), biomolecules are 
randomly distributed over the filaments.  
 
Figure 4: Region-based concentrations of sodium alginate and 
biomolecules in a hybrid tissue scaffold.  
 
Controlling material composition in different regions provides 
control release of loaded biomolecules temporally. Changing 
the incorporated bio-molecules distribution and material 
concentrations provides a way to control release kinetics 
spatially. Higher bio-molecule concentrations in specific sites 
result in higher amount of cumulative release. Material 
concentration however mediates release kinetic rate rather than 
changing cumulative release such as higher alginate 
concentration slows down release kinetics and vice versa [12]. 
 
Figure 5: (a) Fabricated porous scaffold with highlighted 
differentiation in microsphere concentration between 0.3-0.6% 
(w/v) (b) and dark field image highlighting loaded microsphere.  
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4. CONCLUSION 
In this paper, release kinetics through engineered tissue 
scaffolds is controlled spatiotemporally to enhance tissue 
regeneration process. Spatial and temporal control enables 
synchronization of tissue regeneration with the release kinetics 
to advance cell proliferation and tissue healing. Spatiotemporal 
control of release kinetics in this paper is achieved by 
fabricating hybrid tissue scaffolds with (i) controlled structural 
geometry and internal architecture with variational porosity and 
(ii) controlled distribution of base material and loaded 
biological modifiers spatially.  
Transition from incorporation of a single modifier to multiple 
modifiers for scaffolding applications might be an engineering 
challenge and promising approach for improved and efficient 
tissue regeneration. As a future direction, tissue scaffolds needs 
to be designed and fabricated in a way that multiple proteins or 
growth factors should be impregnated and released in a specific 
spatial and temporal orientation to mimic the natural tissue 
regeneration process.  
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